VIVE News and Press, Viveve Medical Inc. From 05/13/21

Viveve Medical (VIVE): Q1 GAAP EPS of -$0.80 misses by $0.29.Revenue of $1.45M (+11.5% Y/Y) beats by $0.12M.Shares +0.8%.Press Release For further details see: Viveve Medical EPS misses by $0.29, beats on revenue

Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific markets ENGLEWOOD, CO / ACCESSWIRE / May 13, 2021 / Viveve Medical, Inc. (NASDAQ:VI...

Meeting scheduled to reconvene June 2, 2021 at 12:00 PM Eastern Time Company encourages stockholders to cast their votes ENGLEWOOD, CO / ACCESSWIRE / May 11, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announce...

InMode is a leader in the medical aesthetic devices industry and blows competitors out of the water when comparing financial metrics. The company still possesses many traits of a multi-bagger, such as having high revenue growth, stable margins, and high returns on capital. Our upd...

ENGLEWOOD, CO / ACCESSWIRE / May 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2021 financial results and provide a corporate update after the close of the U.S. financial ma...

Viveve Medical Inc. (NASDAQ:VIVE) traded at a new 52-week low today of $2.45. So far today approximately 2.3 million shares have been exchanged, as compared to an average 30-day volume of 879,000 shares. Viveve Medical Inc designs, develops, manufactures and markets a platform medical te...

ENGLEWOOD, CO / ACCESSWIRE / April 1, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Taiwan Intellectual Property Office (TIPO) recently issued Taiwan Patent No. 1720358 for Viveve's dual-energy technology ...

Viveve Medical, Inc. (VIVE) Q4 2020 Earnings Conference Call March 18, 2021 05:00 p.m. ET Company Representatives Scott Durbin - Chief Executive Officer Jeannie Swindle - Senior Director of Corporate Communications Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Ben Haynor - A...

Viveve Medical (VIVE): FY GAAP EPS of -$16.56 beats by $0.67.Revenue of $5.48M (-16.6% Y/Y) beats by $0.1M.Cash and cash equivalents were $6.5 million as of December 31, 2020, compared to $13.3 million as of December 31, 2019."Pending positive PURSUIT trial results in mid-2022 and subsequent ...

Company continuing to advance its U.S. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intim...